Melanoma trials in Hong Kong

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  Where

  Hksar, Shatin

  Age

  18 years and over

  People

  254 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07492680